Abstract
In a study of 29 cases of histologically confirmed, characterized colposcopically and cytologically, cervical intraepithelial neoplasias 48.3% (14/ 29) of biopsies were positive for human papillomavirus (HPV) type 16 DNA by polymerase chain reaction. We used two oligonucleotide primer pairs (position 215–514 and 606–805) flanking a 300 and a 199 base pair fragment from the early 6 (E6) and early 7 (E7) genes. The results were concordant both with the E6 and with the E7 regions. Of the amplified products 85.7% (12/14) could be confirmed; these carried 16 specific sequences by Southern blot hybridization. HPV 16 DNA was present in 6.7% (2/30) of the colposcopically directed cytologically normal matched control samples using the same methods.
Similar content being viewed by others
References
Broker TR, Chow LT, Chin MT, Rhodes CR, Wolinsky SM, Whitbeck A, Stoler MH (1989) A nuclear portrait of human papillomavirus carcinogenesis. Cancer cell 7:197–208
Czeglédy J, Gergely L, Hernádi Z, Póka R (1989) Detection of human papillomavirus deoxyribonucleic acid in the female genital tract. Med Microbiol Immunol 178:309–314
Evander M, Wadell G (1990) Oligonucleotide primers for DNA amplification of the early regions 1, 6 and 7 from human papillomavirus types 6, 16, 18, 33. Arch Virol (in press)
Franquemont DW, Ward BE, Andersen WA, Crum CP (1989) Prediction of high-risk cervical papillomavirus infection by biopsy morphology. Am J Clin Pathol 92:577–582
Higuchi R (1989) Rapid efficient DNA extraction for PCR from cells or blood. Amplifications. A forum for PCR users. Perkin Elmer Cetus 2:1–3
Howley PM, Schlegel R (1988) The human papillomavirus. Am J Med 85 [suppl 2A]: 155–158
Johnson MA, Blomfield PI, Bevan IS, Woodman CBJ, Young LS (1990) Analysis of human papillomavirus type 16 E6-E7 transcription in cervical carcinomas and normal cervical epithelium using the polymerase chain reaction. J Gen Virol 71:1473–1479
Lorincz AT, Temple GF, Kurman RJ, Jenson AB, Lancaster WD (1987) Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst 79:671–677
Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM (1989) Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer cells 7:209–214
Meanwell CA, Cox MF, Blackledge G, Maitland NJ (1987) HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behaviour of cervical neoplasia. Lancet I:703–707
Melchers WJG, van den Brule A, Walboomers J, de Bruin M, Burger M, Herbrink P, Meijer C, Lindeman J, Quint WGV (1989) Increased detection rate of human papillomavirus in cervical scrapes by the polymerase chain reaction as compared to modified FISH and Southern blot analysis. J Med Virol 27:329–335
Munoz N, Bosch X, Kaldor JM (1988) Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. Br J Cancer 57:1–5
Pater MM, Pater A (1985) Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology 145:313–318
Pao CC, Lin CY, Maa JS, Lai CH, Wu SY, Soong YK (1990) Detection of human papillomaviruses in cervicovaginal cells using polymerase chain reaction. J Infect Dis 161:113–115
Pfister H (1987) Human papillomaviruses and genital cancer. Adv Cancer Res 48:113–147
Richart RM (1987) Causes and management of cervical intraepithelial neoplasia. Cancer 60:1951–1991
Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N (1985) Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350–1354
Shirasawa H, Tomita Y, Kubota K, Kasai T, Sekinya S, Takamizawa H, Simuzu B (1988) Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas. J Virol 62:1022–1027
Van der Brule AJC, Claas ECJ, du Maine M, Melchers WJG, Heimerhorst T, Quint WGV, Lindeman J, Meijer CJLM, Walboomers JMM (1989) Use of anticontamination primers in the polymerase chain reaction for the detection of human papillomavirus genotypes in cervical scrapes and biopsies. J Med Virol 29:20–27
Young LS, Bevan IS, Johnson MA, Blomfield PI, Bromidge T, Maitland NJ, Woodman CBJ (1989) The polymerase chain reaction: a new epidemilogical tool for investigating cervical human papillomavirus infection. Br Med J 298:14–18
Yutsudo M, Okamoto Y, Hakura A (1988) Functional dissociation for transforming genes of human papillomavirus type 16. Virology 166:594–597
zur Hausen H (1986) Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet II:489–491
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Czeglédy, J., Evander, M., Veres, L. et al. Detection of transforming gene regions of human papillomavirus type 16 in cervical dysplasias by the polymerase chain reaction. Med Microbiol Immunol 180, 37–43 (1991). https://doi.org/10.1007/BF00191699
Issue Date:
DOI: https://doi.org/10.1007/BF00191699